Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 6310 of 6351
-
New scan aims to spot brain bleeding after stroke – but study stalls
Diagnosis Stopped earlyCerebral haemorrhages following reperfusion treatments involve not only rupture of the blood-brain barrier, but also direct damage to vessels related to the equipment used and secondary toxicity to thrombolytics. The rupture of the blood-brain barrier which results from ischemia …
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
New study maps health habits of blood thinner users
Knowledge-focused CompletedThe primary aim of this study is to describe and develop a cross-sectional profile of the level of the main health determinants in the Italian anticoagulated population (disease knowledge; self-efficacy; health literacy; quality of life). Indeed, evaluate how socio-demographic an…
Sponsor: IRCCS Policlinico S. Donato • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Tiny study checks if new brain scanner tracer works reliably
Knowledge-focused CompletedThe purpose of this study is to understand the reliability of \[18F\]-FTC-146 brain uptake in healthy controls.
Phase 1 • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
EHR nudge study to curb dangerous drug mixes in seniors pulled before start
Knowledge-focused CancelledPolypharmacy is common among older adults in the United States and is associated with harms such as adverse drug reactions and higher costs of care. This pilot-phase project is designed to test two electronic health record (EHR)-based behavioral economic nudges to help primary ca…
Sponsor: RAND • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Drug interaction study tests cancer Drug's effect on diabetes medication
Knowledge-focused CompletedThe main purpose of this study is to assess the effect of selpercatinib on how fast repaglinide gets into the blood stream and how long it takes the body to remove it when administered in healthy participants. Information about safety and tolerability will be collected. The study…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Smart toothbrush trial for cleft surgery kids pulled before it started
Symptom relief CancelledAlveolar bone graft is an essential step in the primary surgical treatment of unilateral or bilateral cleft lip and palate. The procedure involves repairing the alveolar cleft by an autologous iliac bone graft. Clinical experience suggests that a large number of the post-operati…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Tiny study reveals how a new brain drug travels through the body
Knowledge-focused CompletedThe primary objective of this trial is to investigate the absolute oral bioavailability of BI 425809 administered as tablet (Test, T) compared to \[C-14\]-BI 425809 administered as intravenous microtracer (Reference, R).
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Early safety check for new drug MT-6345 in healthy people
Knowledge-focused Stopped earlyThe purpose of this study is to Investigate the Safety, Tolerability and Pharmacokinetics of MT-6345 in Healthy Subjects.
Phase 1 • Sponsor: Tanabe Pharma America, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Vitamin d breast cancer study pulled before it began
Knowledge-focused CancelledHigh-doses of Vitamin D (VD) may be used as targeted therapy against breast cancer. The investigators will assess the effect of high dose VD on the following biomarkers in the breast cancer cells: VDR, estrogen receptor (ER), progesterone receptor (PR), epidermal growth factor re…
Phase 1/2 • Sponsor: Eli Avisar, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Community cancer Centers' testing practices under review
Knowledge-focused CancelledThis trial assesses current biomarker testing practices for common solid cancers in precision oncology in the community setting. Cancer biomarkers are used for diagnosing the disease, determining prognosis, predicting response to a targeted therapy, or monitoring response to ther…
Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
New math could make clinical trials more accurate
Knowledge-focused CompletedMost of randomized clinical trials (RCT) using time-to-event criteria as the primary endpoint are designed, powered and analyzed based on an hypothetical hazard ratio (HR) corresponding to the targeted effect size between experimental and control arms. Usually, one assumes that p…
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:37 UTC
-
Blood cancer chemo and adrenal risk study pulled before start
Knowledge-focused CancelledA recent meta-analysis involving 3753 patients treated with corticosteroids notes that the population with the highest prevalence of biological IS (68%) is onco-hematology. However, it is also the least studied population with no recent and significant prevalence study. A recent …
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
New tooth filling tested for better smile appeal
Symptom relief CompletedTo compare a newly developed filling composite to a current filling composite system. Two restorations will be placed in each subject, one using system A and one using system B. The first system listed in the randomization pair will be placed on first tooth (#4-#13), and the seco…
Sponsor: Erica Teixeira • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Brain drug SAGE-718 tested in healthy people – no cure yet
Knowledge-focused CompletedThis study is a Phase 1, randomized, double-blind, placebo-controlled study of multiple doses of SAGE-718 using ketamine challenge to evaluate the electrophysiology, safety, tolerability, and pharmacokinetics in healthy subjects.
Phase 1 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:02 UTC
-
Experimental stent graft for aortic tear tested in single patient
Disease control Stopped earlyThe purpose of this early feasibility study is to investigate the outcome of selected patients with ascending thoracic aortic pathologies including type A aortic dissection, who are suitable for endovascular repair with the Medtronic Valiant PS-IDE Stent Graft System with the Cap…
Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Liver damage study in head and neck cancer abandoned after just 2 patients
Knowledge-focused Stopped earlyTobacco and alcohol are the two major risk factors for upper respiratory tract cancer (VADS).
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New drug LY3451838 tested in healthy people for safety
Knowledge-focused CompletedThe study has two parts. In Part A, single increasing doses of LY3451838 will be administered intravenously (into a vein). In Part B, a single dose of LY3451838 will be administered subcutaneously (just under the skin).
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:32 UTC
-
Small study suggests meal timing may influence sleep and sugar control
Knowledge-focused CompletedThe purpose of this research study is to see how the timing of eating impacts participants sleep and how the body responds to sugar.
Sponsor: Colorado State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Early safety check of new drug LY3463251 halted before completion
Knowledge-focused Stopped earlyThe purpose of this study is to evaluate the safety and tolerability (side effects) of single (Part A) and multiple (Part B) doses of the study drug when it is administered subcutaneously (under the skin) into the abdomen. This is a two-part study. Participants will enroll in on…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Delirium detection study in Kids' ICU withdrawn before starting
Knowledge-focused CancelledThe purpose of this study is to introduce delirium detection and try to determine the prevalence of delirium in Pediatric Intensive Care Unit (PICU) using a validated tool : the Cornell Assessment of Pediatric Delirium (CAPD) for every patient twice a day.
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC